Critic at Large

» funding and collaboration

Most Recent

image: Opinion: Fixing Science’s Human Bias

Opinion: Fixing Science’s Human Bias

By and | September 1, 2016

It’s time to accelerate the conversation about why the research community is still not diverse.

3 Comments

image: The Global Science Era

The Global Science Era

By | May 1, 2016

As international collaboration becomes increasingly common, researchers must work to limit their own biases and let cultural diversity enhance their work.

2 Comments

image: Remaking Nature

Remaking Nature

By | August 1, 2013

Synthetic biologists need to work together with conservationists to understand the environmental consequences of this new technology.

6 Comments

image: Medicines for the World

Medicines for the World

By | October 1, 2012

A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.

0 Comments

image: Food for Thought

Food for Thought

By | June 1, 2012

Plant research remains grossly underfunded, despite the demand for increased crop production to support a growing population.

6 Comments

image: Cooking Up Creative Solutions

Cooking Up Creative Solutions

By | May 1, 2012

More collaborators and more data are the key ingredients.

0 Comments

image: Hard and Harder

Hard and Harder

By | June 5, 2011

The path to eradicating malaria in Africa involves much more than just a vaccine.

18 Comments

image: Another Revolution Needed?

Another Revolution Needed?

By | March 1, 2011

Counting the many plagues that threaten research in the Middle East and North Africa region

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech